10th Global Drug Delivery & Formulation Summit

11th – 13th March 2019 | Berlin

Innovative solutions to the greatest challenges in pharmaceutical development

Thanks to everyone who contributed to and attended the DDF Summit 2018.

The agenda covered new technologies, concepts and case studies in areas such as:

  • Less traditional delivery routes including nasal, ocular & subcutaneous
  • Targeted and controlled release technologies and nanoparticles
  • Increasing stability of amorphous solid dispersions
  • QbD in biopharmaceutical development
  • Formulation strategies for multiple injection dosing
  • Oral delivery of peptides
  • Continuous manufacturing and processing for improved efficiency
  • User friendly technologies for improving patient convenience and compliance
  • Regulatory strategies for combination products
  • Drug stability and material selection in combination products

If you’re interested in attending in 2019 as either an attendee, speaker or commercial partner, please get in touch.

Register Now

2018 Speakers

Yvonne Perrie

University of Strathclyde

Chair Drug Delivery

Yves Robin

PMC Isochem (PMC Group)

R&D Director

Yash Kapoor


Associate Principal Scientist

Wolfgang Beier



Vladimir P. Torchilin

Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University

Distinguished Professor and Director

Tonio Hoche

Roche Switzerland

Device Engineer

Tom Lawrie-Fussey

Cambridge Design Partnership

Digital Services Specialist

Thomas Rades

University of Copenhagen

Chair Pharmaceutical Sciences

Thakur Raj Singh

Queen's University Belfast

Senior Lecturer in Pharmaceutics

Tarik Khan


Group Leader, Late-Stage Pharmaceutical and Processing Development

Swapnil Khadke

University of Strathclyde

Pharmaceutical Formulation and Development Specialist

Svend Ludvigsen

Novo Nordisk

Senior Scientific Director

Surendera Tyagi

Fresenius Kabi USA

Senior Vice President Head Innovation & Development Center

Stephen Buckley

Novo Nordisk

Head of Department, Absorption and Biological MS

Stéphanie Bureau


R&D Director

Sofiya Yashchuk


Technical Applications Specialist

Scott Ariagno


Head, Infusion and Reconstitution Systems / Director, Device Development and External Manufacturing

Sabine Eichling


Senior Scientist II, NBE High-Throughput and Advanced Formulation Sciences

Ruchi Gupta


Scientist I

Robert Meyer


Head of Innovation Technology Group, Pharmaceutical Commercialization

Richard Zajicek


Head of Formulation Development, Cell and Gene Therapy Group

Richard Wedge

Pfizer Ltd

Compliance Lead

Richard Featherstone

Medical Device Usability Ltd

Managing Director

Rene Van Nostrum

Utrecht University

Associate Professor

Professor Edward Hæggström


Chief Executive Officer

Professor Duncan Craig

UCL School of Pharmacy

Director, Chair in Drug Delivery

Prof. Dr. Sven Stegemann


Director Pharmaceutical Business Development

Prof. Dr. Sarah Hedtrich

Freie Universitat Berlin


Prof. Dr. Karsten Mäder

Martin Luther University Halle-Wittenberg

Head of Pharmaceutical Technology

Philippe Lienard


CMC Discovery Coordinator

Patrick Garidel

Boehringer Ingelheim

Associate Director Protein Science

Patrick Anquetil

Portal Instruments


Olivier Brass

Sanofi Pasteur

Formulation Scientist

Olaf Queckenberg

Bayer AG

Head of Chemical & Pharmaceutical Development

Nikki Whitfield

Quotient Sciences

Vice President CDMO Services

Muriel Didier


Human Factors Team Head

Mostafa Nakach


Head of Pharmaceutical engineering-Paris

Mike Hooven

Enable Injections, Inc.

President and CEO

Martin McLoughlin

Bristol-Myers Squibb

Head of Device Development

Markus Krummer


Head of Continuous Manufacturing

Márcio Temtem


Associate Director for Drug Product Development

Manfred Ogris

Division of Clinical Pharmacy and Diagnostics Vienna University

Professor Pharmaceutical Sciences, Head of the Laboratory for Macromolecular Cancer Therapeutics

Lorenz Meinel

Wurzburg University

Chair for Drug Formulation and Delivery

Kristof Kimpe

Janssen Pharmaceutica (a division of Johnson & Johnson)

Principal Scientist

Kenneth Graham


Senior Fellow Scientist, Associate Director

Kathrin Spielberger


Lab Head Formulation Development

Kaspar van den Dries

Patheon, Part of Thermo Fisher Scientific

Senior Director and Principle Scientist, Solid Dose Development

Jukka Rantanen

University of Copenhagen

Professor Pharmaceutical Technology

Juan Irache

University of Navarra

Professor of Pharmaceutical Technology

Joel Richard


Senior Vice President, Peptides

Joe Barco

Unchained Labs

Senior Director of Marketing

Jerome Mantanus


Head of Formulation and Process Characterisation

Jean-René Authelin


Global director of Pharmaceutical Engineering

Jatin Patel

Bristol-Myers Squibb

Head – Oral Product Design & Development

James A. McCoy

BD Medical Pharmaceutical Systems

Staff Scientist, Head of Sterilization R&D/Innovation Center

Isabel Sequeira Lopes


Senior Formulation Scientist/Project Coordinator

Herve Barre

BD Medical Pharmaceutical Systems

Chef de projet Sterilisation WW, Industrial Engineer

Helen Williams


Associate Principal Scientist

Helen Hao Hou


Scientist, Small Molecule Pharmaceutical Sciences

Hannah Batchelor

University of Birmingham

Senior Lecturer in Pharmaceutics, Formulation and Drug Delivery

Gunilla Petersson

Astrazeneca Sweden

Science & Innovation Director

Gregoire Schwach

EU F. Hoffmann-La Roche

Head of Drug Delivery, Pharmaceutical Development and Supplies Biologics

Giustino Di Pretoro

Johnson & Johnson

Associate Director

Gabriele Sadowski

TU Dortmund University

Faculty Head

Fred Monsuur

W.R. Grace

TCS and Business Development Manager Excipients

Frantz Elbaz


Formulator Project Leader and Pharm Development QBD Network Leader

Filippos Kesisoglou


Senior Principal Scientist, Biopharmaceutics and Pharmaceutical Sciences

Ellen Verheyen


Senior scientist – Stability Expert

Eleonora Cerasoli


Senior Research Scientist

Dr. Roberto Castangia

biopharma group

Global Sales Manager

Dr. Meinolf Brackhagen

Dow Chemical Company

Senior TS&D Scientist / Pharma

Dr. Matthias Rischer

Losan Pharma

Director Drug Delivery & Innovation Projects

Dr. Jin Wang-Lai

Adare Pharma

Senior Director - Pharmaceutical Development

Dr. Finn Bauer

Merck KGaA

Head of Solid Formulations R&D

Dr. Christian Lotz


Director, Business Development

Dr. Amrit Paudel

Graz University of Technology

Assistant Professor Institute of Process and Particle Engineering

Dr Bastiaan Dickhoff

DFE Pharma

Product Application Specialist OSD

Daniel Schweizer


DP Project Lead TD NBE’s

Clive Wilson

University of Strathclyde

J.P. Professor of Pharmaceutics

Christophe Tistaert

Janssen Belgium

Senior Scientist

Christoph Brandenbusch

University of Dortmund

Associate Professor

Carsten Olbrich


Product Quality Steward Eylea and Anetumab Ravstantine

Carina Van Eester

Datwyler Sealing Solutions

Platform leader PFS and cartridges

Brian Henry


Vice President Drug Product Design

Bjørg Hunter


Device Engineering Manager

Bertil Abrahamsson


Senior Principal Scientist

Bernd Riebesehl

Novartis Pharma AG

Distinguished Fellow

Bernard van Eerdenbrugh


Pre-clinical Formulation Expert, Chem. & Pharmaceut. Profiling Technical R&D

Bastiaan de Leeuw

Cambridge Design Partnership

Head of Business Development – Drug Delivery

Aniket Badkar


Associate Director Biologics Product Development

Andreas Bernkop-Schnürch

University of Innsbruck



2018 Highlights

Device Development Stream